Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
233 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Show all (12)
  • (-) Currently Recruiting (2)
  • Closed (10)

Medical Condition

  • Show all (233)
  • Addiction (4)
  • Allergy, Asthma, & Immunology (1)
    • (-) Asthma (1)
  • Autoimmune Disorders (3)
  • Bone & Muscle (2)
  • Cancer (10)
  • COVID-19 (Coronavirus) (8)
  • Diabetes (7)
  • Ear, Nose and Throat (7)
  • Endocrine & Metabolic Disease (2)
  • Gastrointestinal and Digestive Diseases (3)
  • Healthy Volunteers (46)
  • Heart Disease (21)
  • Infectious Disease (11)
  • Insomnia (1)
  • Liver Disease (15)
    • Cirrhosis of the Liver (1)
    • Liver Failure (1)
    • (-) MASH (formerly NASH) (1)
  • Lung Disease (2)
  • Neurological Disorders (31)
  • Nutrition (2)
  • Obesity (8)
  • Obstetrics & Gynecology (10)
  • Pediatrics (14)
  • Psychiatric Disorders (7)
  • Rehabilitation (2)
  • Stroke (2)
  • Transplant (13)
  • Vascular Conditions (1)
Displaying 1 - 2 of 2

Study to Test if BI 3802876 is Tolerated in People W/ Compensated Liver Cirrhosis Due to Metabolic Dysfunction-Associated Steatohepatitis

Condition: Liver Disease / MASH (formerly NASH)
Investigator: Julia Wattacheril, MD, MPH
Status: Currently Recruiting
The purpose of this research study is to determine how well BI3802876 is tolerated in people living with cirrhosis due to a liver condition called metabolic dysfunction-associated steatohepatitis (MASH, formerly known as NASH). The study medication, BI3802876, is investigational, meaning it has not yet been approved by the United States Food and Drug…
Read More

CAUSE: Childhood Asthma in Urban Settings

Condition: Allergy, Asthma, & Immunology / Asthma
Investigator: Meyer Kattan, MD
Status: Currently Recruiting
We are interested in learning more about these diseases and how to treat them. Our research program is conducting several studies including: a study to learn if treatment with a drug named dupilumab can help reduce asthma attacks in children, a study to observe a specific type of irritation in the lungs and how it relates to asthma symptoms, and more! If…
Read More
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2026 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science